Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$1,888,774
+$98,496 QoQ
Shares Held
7,437
+1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.88%
of 13F equity value
Holder Rank
#2,401
of 4,664 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Derivatives in JNJ
reported options exposure · as of Sep 30, 2021CallValue
$16,150
CallShares
100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keudell/Morrison Wealth Management holds $22,085,611 across 13 Drug Manufacturers - General names. JNJ ranks #3 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,989 | $5,983,956 | |
| 2 | ABBV |
AbbVie Inc.
|
20,064 | $5,048,904 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
7,437 | $1,888,774 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
14,835 | $1,874,253 | |
| 5 | AMGN |
Amgen Inc
|
4,952 | $1,793,218 | |
| 6 | MRK |
Merck & Co., Inc.
|
13,268 | $1,704,938 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
19,945 | $1,149,230 | |
| 8 | SNY |
Sanofi
|
14,344 | $611,915 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,888,774 | 7,437 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $1,790,278 | 7,324 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,805,017 | 8,722 | Shares | Sole | 2026-02-06 | |
| 2025-06-30 | $1,538,498 | 10,072 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,787,921 | 10,781 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,548,157 | 10,705 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1,492,734 | 9,211 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,214,589 | 8,310 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,271,531 | 8,038 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,313,010 | 8,377 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,358,763 | 8,724 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $1,461,872 | 8,832 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $1,384,615 | 8,933 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $1,566,178 | 8,866 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,453,740 | 8,899 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,477,238 | 8,322 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $1,509,645 | 8,518 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $1,562,895 | 9,136 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,537,803 | 9,522 | Shares | Sole | 2021-12-08 | |
| 2021-09-30 | $16,150 | 100 | Call | Sole | 2021-12-08 | |
| 2021-06-30 | $1,472,281 | 8,937 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $1,493,119 | 9,085 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $1,431,528 | 9,096 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,400,216 | 9,405 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $1,309,405 | 9,311 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $1,233,277 | 9,405 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||